Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Hemostam Inj 150 mcg Solution is a Health Canada–registered veterinary drug (DIN 00654620) held by Rafter 8 Products Inc, containing Vitamin B12. Health Canada lists its status as Cancelled Post Market (status date 30 May 2023). Nexara Health has matched 1 registration of Vitamin B12 across 1 other regulated market.

Health Canada registration

DIN00654620
Brand nameHemostam Inj
Active ingredientVitamin B12
Strength150 mcg
Dosage formSolution
RouteIntramuscular ; Intravenous
CompanyRafter 8 Products Inc
StatusCancelled Post Market — 30 May 2023
ClassVeterinary
ATCA11JB VITAMINS WITH MINERALS
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Vitamin B12 registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
MalaysiaGNC Vitamin B-12 1000 mcg TabletGnc Livewell Malaysia Sdn. Bhd.Non PrescriptionPRODUCT APPROVEDNPRA

See every manufacturer of Vitamin B12 worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Hemostam Inj (DIN 00654620) marketed in Canada?

No. Health Canada lists DIN 00654620 as Cancelled Post Market as of 30 May 2023.

Who holds the Canadian licence for this product?

Rafter 8 Products Inc is the company of record in the Health Canada Drug Product Database.

Is Vitamin B12 registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00654620, status date 2023-05-30; national medicine registries: NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00654620, status date 2023-05-30; national medicine registries: NPRA.

Health Canada Drug Product Database (DPD), DIN 00654620, status date 2023-05-30; national medicine registries: NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.